Upregulation of the Wnt/β-catenin pathway induced by transforming growth factor-β in hypertrophic scars and keloids

被引:158
作者
Sato, Madoka [1 ]
机构
[1] Dokkyo Univ, Sch Med, Dept Dermatol, Mibu, Tochigi 3210293, Japan
关键词
Smad3; p38; MAPK; fibrosis; wound healing;
D O I
10.2340/00015555-0101
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Hypertrophic scars and keloids represent a dysregulated response to cutaneous wounds, which results in an excessive deposition of collagen. Transforming growth factor-beta (TGF-beta) is the key regulator in the pathogenesis of fibrosis. Accumulating evidence suggests that Wnt signalling and its effector beta-catenin also play an important role in wound healing. The role of Wnt/beta-catenin signalling in TGF-beta induced collagen deposition in hypertrophic scars and keloids was studied. Transcriptional assays and Western blotting was performed using fibroblast cell lines established from normal skin and hypertrophic scar tissue. Immunohistochemical studies were performed using scar tissues. We provide evidence that TGF-beta induces activation of beta-catenin mediated transcription in human dermal fibroblasts via the Smad3 and p38 MAPK pathways. Immunohistochemical studies demonstrated that beta-catenin protein levels are elevated in hypertrophic scar and keloid tissues. This finding may be relevant to the pathogenesis of hypertrophic scars and keloids.
引用
收藏
页码:300 / 307
页数:8
相关论文
共 32 条
  • [1] Arakawa M, 1996, BRIT J DERMATOL, V134, P863
  • [2] Barker N, 2000, ADV CANCER RES, V77, P1
  • [3] Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars
    Bock, O
    Yu, HY
    Zitron, S
    Bayat, A
    Ferguson, MWJ
    Mrowietz, U
    [J]. ACTA DERMATO-VENEREOLOGICA, 2005, 85 (03) : 216 - 220
  • [4] Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β:: Involvement of Smad 3
    Chen, SJ
    Yuan, WH
    Mori, Y
    Levenson, A
    Trojanowska, M
    Varga, J
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (01) : 49 - 57
  • [5] Growth factors regulate β-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing
    Cheon, SS
    Nadesan, P
    Poon, R
    Alman, BA
    [J]. EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) : 267 - 274
  • [6] β-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and aggressive fibromatosis and hyperplastic cutaneous wounds
    Cheon, SS
    Cheah, AYL
    Turley, S
    Nadesan, P
    Poon, R
    Clevers, H
    Alman, BA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) : 6973 - 6978
  • [7] Aberrant Wnt/β-catenin pathway activation in idiopathic pulmonary fibrosis
    Chilosi, M
    Poletti, V
    Zamò, A
    Lestani, M
    Montagna, L
    Piccoli, P
    Pedron, S
    Bertaso, M
    Scarpa, A
    Murer, B
    Cancellieri, A
    Maestro, R
    Semenzato, G
    Doglioni, C
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) : 1495 - 1502
  • [8] Differential expression of transforming growth factor-β receptors I and II and activation of Smad 3 in keloid fibroblasts
    Chin, GS
    Liu, W
    Peled, Z
    Lee, TY
    Steinbrech, DS
    Hsu, M
    Longaker, MT
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2001, 108 (02) : 423 - 429
  • [9] Ets1 is an effector of the transforming growth factor β (TGF-β) signaling pathway and an antagonist of the profibrotic effects of TGF-β
    Czuwara-Ladykowska, J
    Sementchenko, VI
    Watson, DK
    Trojanowska, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) : 20399 - 20408
  • [10] Insulin-like growth factor-I enhances transforming growth factor-β-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts
    Daian, T
    Ohtsuru, A
    Rogounovitch, T
    Ishihara, H
    Hirano, A
    Akiyama-Uchida, Y
    Saenko, V
    Fujii, T
    Yamashita, S
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 120 (06) : 956 - 962